CLINICAL_TRIALS
trial_result
· 2019-10-09
Clinical Trial Update: Evaluation of a New Anti-cancer Immunotherapy in Patients With Non-operable and Progressing Metastatic Cutaneous Melanoma [Phase 1]
Summary
Phase 1 trial update evaluating a new anti-cancer immunotherapy in non-operable, progressing metastatic cutaneous melanoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: GlaxoSmithKline | Conditions: Melanoma | Phase 1 | Status: COMPLETED | Results posted: 2019-10-09